Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan.
Saved in:
| Title: | Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan. |
|---|---|
| Authors: | Molfino, Alessio1 (AUTHOR) alessio.molfino@uniroma1.it, Imbimbo, Giovanni1,2 (AUTHOR), Pisegna, Simona1,2 (AUTHOR), Scagnoli, Simone2 (AUTHOR), Alabiso, Claudia1 (AUTHOR), Ardovino, Massimiliano1 (AUTHOR), Gallicchio, Carmen1 (AUTHOR), Rizzo, Veronica2 (AUTHOR), Botticelli, Andrea2 (AUTHOR) |
| Source: | Cancers. Sep2025, Vol. 17 Issue 18, p3063. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
